Proliferation- and cytotoxic immune signatures identify chemotherapy-responsive bladder tumors in a molecular subtype dependent manner.
Aymeric Zadoroznyj(Medicon Village), Gottfrid Sjödahl(Lund University), Carl-Adam Mattsson(Lund University), Seth P. Lerner(Baylor College of Medicine), David J. McConkey(Johns Hopkins University), Lena Tran(Medicon Village), Thomas W. Flaig(University of Colorado Denver), Catherine M Tangen, Roland Seiler, Peter C Black, Fredrik Liedberg, Carina Bernardo(Lund University), Pontus Eriksson, Mattias Höglund(Lund University)
Cited by 0
Related Papers
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
|New England Journal of Medicine|2012|2.8k
A Consensus Molecular Classification of Muscle-invasive Bladder Cancer
|European Urology|2019|1.4k